nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—SLC22A1—hematologic cancer	0.302	0.766	CbGaD
Pipotiazine—ALB—hematologic cancer	0.092	0.234	CbGaD
Pipotiazine—SLC22A1—Cytarabine—hematologic cancer	0.0305	0.0558	CbGbCtD
Pipotiazine—CYP1A2—Anagrelide—hematologic cancer	0.0298	0.0545	CbGbCtD
Pipotiazine—SLC22A1—Cladribine—hematologic cancer	0.0288	0.0527	CbGbCtD
Pipotiazine—SLC22A1—Imatinib—hematologic cancer	0.0265	0.0484	CbGbCtD
Pipotiazine—CYP2D6—Lomustine—hematologic cancer	0.0158	0.029	CbGbCtD
Pipotiazine—CYP1A2—Carmustine—hematologic cancer	0.0157	0.0286	CbGbCtD
Pipotiazine—ALB—Imatinib—hematologic cancer	0.0155	0.0284	CbGbCtD
Pipotiazine—CYP2D6—Idarubicin—hematologic cancer	0.0141	0.0258	CbGbCtD
Pipotiazine—CYP2C19—Bortezomib—hematologic cancer	0.0137	0.0251	CbGbCtD
Pipotiazine—CYP1A2—Methoxsalen—hematologic cancer	0.0133	0.0244	CbGbCtD
Pipotiazine—CYP1A2—Bortezomib—hematologic cancer	0.0127	0.0232	CbGbCtD
Pipotiazine—CYP1A2—Daunorubicin—hematologic cancer	0.0121	0.0222	CbGbCtD
Pipotiazine—CYP2D6—Hydroxyurea—hematologic cancer	0.012	0.0219	CbGbCtD
Pipotiazine—CYP2C19—Thalidomide—hematologic cancer	0.012	0.0219	CbGbCtD
Pipotiazine—CYP1A2—Alitretinoin—hematologic cancer	0.0119	0.0217	CbGbCtD
Pipotiazine—CYP2C19—Teniposide—hematologic cancer	0.0114	0.0209	CbGbCtD
Pipotiazine—CYP1A2—Thalidomide—hematologic cancer	0.011	0.0202	CbGbCtD
Pipotiazine—CYP3A4—Bexarotene—hematologic cancer	0.0108	0.0198	CbGbCtD
Pipotiazine—CYP2C19—Ifosfamide—hematologic cancer	0.0105	0.0193	CbGbCtD
Pipotiazine—CYP2D6—Bortezomib—hematologic cancer	0.0104	0.0191	CbGbCtD
Pipotiazine—ALB—Prednisone—hematologic cancer	0.0102	0.0187	CbGbCtD
Pipotiazine—CYP3A4—Busulfan—hematologic cancer	0.0101	0.0184	CbGbCtD
Pipotiazine—CYP3A4—Lomustine—hematologic cancer	0.0101	0.0184	CbGbCtD
Pipotiazine—CYP2C19—Imatinib—hematologic cancer	0.0101	0.0184	CbGbCtD
Pipotiazine—ALB—Irinotecan—hematologic cancer	0.0097	0.0177	CbGbCtD
Pipotiazine—CYP1A2—Dacarbazine—hematologic cancer	0.0095	0.0174	CbGbCtD
Pipotiazine—CYP1A2—Imatinib—hematologic cancer	0.00929	0.017	CbGbCtD
Pipotiazine—CYP3A4—Thiotepa—hematologic cancer	0.00898	0.0164	CbGbCtD
Pipotiazine—CYP2D6—Imatinib—hematologic cancer	0.00765	0.014	CbGbCtD
Pipotiazine—CYP1A2—Dasatinib—hematologic cancer	0.00746	0.0136	CbGbCtD
Pipotiazine—CYP3A4—Methoxsalen—hematologic cancer	0.00698	0.0128	CbGbCtD
Pipotiazine—CYP2D6—Nilotinib—hematologic cancer	0.00696	0.0127	CbGbCtD
Pipotiazine—CYP2D6—Vinorelbine—hematologic cancer	0.0069	0.0126	CbGbCtD
Pipotiazine—CYP3A4—Bortezomib—hematologic cancer	0.00664	0.0121	CbGbCtD
Pipotiazine—CYP2C19—Prednisone—hematologic cancer	0.00663	0.0121	CbGbCtD
Pipotiazine—CYP3A4—Daunorubicin—hematologic cancer	0.00635	0.0116	CbGbCtD
Pipotiazine—CYP3A4—Cytarabine—hematologic cancer	0.0056	0.0102	CbGbCtD
Pipotiazine—CYP3A4—Teniposide—hematologic cancer	0.00552	0.0101	CbGbCtD
Pipotiazine—ALB—Methotrexate—hematologic cancer	0.00513	0.00938	CbGbCtD
Pipotiazine—CYP3A4—Ifosfamide—hematologic cancer	0.00509	0.00931	CbGbCtD
Pipotiazine—CYP3A4—Imatinib—hematologic cancer	0.00487	0.00889	CbGbCtD
Pipotiazine—CYP1A2—Etoposide—hematologic cancer	0.00465	0.00849	CbGbCtD
Pipotiazine—CYP3A4—Ruxolitinib—hematologic cancer	0.00458	0.00837	CbGbCtD
Pipotiazine—CYP3A4—Nilotinib—hematologic cancer	0.00442	0.00808	CbGbCtD
Pipotiazine—CYP3A4—Vinorelbine—hematologic cancer	0.00439	0.00801	CbGbCtD
Pipotiazine—CYP2D6—Vinblastine—hematologic cancer	0.00425	0.00777	CbGbCtD
Pipotiazine—CYP2C19—Dexamethasone—hematologic cancer	0.00414	0.00757	CbGbCtD
Pipotiazine—CYP3A4—Triamcinolone—hematologic cancer	0.00401	0.00733	CbGbCtD
Pipotiazine—CYP3A4—Dasatinib—hematologic cancer	0.00391	0.00714	CbGbCtD
Pipotiazine—CYP3A4—Mitoxantrone—hematologic cancer	0.00386	0.00705	CbGbCtD
Pipotiazine—CYP3A4—Betamethasone—hematologic cancer	0.00344	0.00629	CbGbCtD
Pipotiazine—CYP3A4—Prednisolone—hematologic cancer	0.0034	0.0062	CbGbCtD
Pipotiazine—CYP3A4—Prednisone—hematologic cancer	0.00321	0.00586	CbGbCtD
Pipotiazine—CYP2D6—Dexamethasone—hematologic cancer	0.00315	0.00575	CbGbCtD
Pipotiazine—CYP3A4—Irinotecan—hematologic cancer	0.00304	0.00555	CbGbCtD
Pipotiazine—CYP3A4—Vinblastine—hematologic cancer	0.0027	0.00494	CbGbCtD
Pipotiazine—CYP3A4—Vincristine—hematologic cancer	0.00266	0.00485	CbGbCtD
Pipotiazine—CYP2D6—Doxorubicin—hematologic cancer	0.00261	0.00477	CbGbCtD
Pipotiazine—CYP3A4—Etoposide—hematologic cancer	0.00243	0.00445	CbGbCtD
Pipotiazine—CYP3A4—Dexamethasone—hematologic cancer	0.002	0.00366	CbGbCtD
Pipotiazine—CYP3A4—Doxorubicin—hematologic cancer	0.00166	0.00303	CbGbCtD
Pipotiazine—Quetiapine—H1F0—hematologic cancer	0.000346	0.182	CrCbGaD
Pipotiazine—Acepromazine—SLC22A1—hematologic cancer	0.000191	0.101	CrCbGaD
Pipotiazine—Thioproperazine—SLC22A1—hematologic cancer	0.000186	0.0983	CrCbGaD
Pipotiazine—Thiothixene—SLC22A1—hematologic cancer	0.000183	0.0967	CrCbGaD
Pipotiazine—Clomipramine—GSTP1—hematologic cancer	0.000157	0.0826	CrCbGaD
Pipotiazine—Chlorpromazine—SLC22A1—hematologic cancer	9.95e-05	0.0524	CrCbGaD
Pipotiazine—Imipramine—SLC22A1—hematologic cancer	9.89e-05	0.0522	CrCbGaD
Pipotiazine—Domperidone—ABCB1—hematologic cancer	7.41e-05	0.039	CrCbGaD
Pipotiazine—Triflupromazine—ABCB1—hematologic cancer	5.99e-05	0.0316	CrCbGaD
Pipotiazine—Acepromazine—ALB—hematologic cancer	5.81e-05	0.0306	CrCbGaD
Pipotiazine—Thioproperazine—ALB—hematologic cancer	5.68e-05	0.0299	CrCbGaD
Pipotiazine—Thiothixene—ALB—hematologic cancer	5.59e-05	0.0295	CrCbGaD
Pipotiazine—Fluphenazine—ABCB1—hematologic cancer	4.61e-05	0.0243	CrCbGaD
Pipotiazine—Clomipramine—ALB—hematologic cancer	4.42e-05	0.0233	CrCbGaD
Pipotiazine—Clomipramine—ABCB1—hematologic cancer	4.22e-05	0.0222	CrCbGaD
Pipotiazine—Promethazine—ABCB1—hematologic cancer	3.74e-05	0.0197	CrCbGaD
Pipotiazine—Trifluoperazine—ABCB1—hematologic cancer	3.69e-05	0.0194	CrCbGaD
Pipotiazine—Quetiapine—ABCB1—hematologic cancer	3.57e-05	0.0188	CrCbGaD
Pipotiazine—Chlorpromazine—ALB—hematologic cancer	3.03e-05	0.016	CrCbGaD
Pipotiazine—Chlorpromazine—ABCB1—hematologic cancer	2.89e-05	0.0152	CrCbGaD
Pipotiazine—Imipramine—ABCB1—hematologic cancer	2.88e-05	0.0152	CrCbGaD
Pipotiazine—CYP3A4—Metabolism—MTR—hematologic cancer	3.63e-06	6.38e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.63e-06	6.38e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	3.6e-06	6.35e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NOTCH1—hematologic cancer	3.6e-06	6.34e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—MTHFR—hematologic cancer	3.6e-06	6.33e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CD80—hematologic cancer	3.58e-06	6.31e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	3.58e-06	6.3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	3.58e-06	6.3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KIT—hematologic cancer	3.58e-06	6.3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—NRAS—hematologic cancer	3.58e-06	6.3e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.56e-06	6.26e-05	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.55e-06	6.24e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CD80—hematologic cancer	3.52e-06	6.21e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	3.52e-06	6.2e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KIT—hematologic cancer	3.52e-06	6.2e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	3.52e-06	6.2e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.51e-06	6.19e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PTPN11—hematologic cancer	3.51e-06	6.19e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	3.51e-06	6.17e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.49e-06	6.15e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—PIK3CA—hematologic cancer	3.48e-06	6.13e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HRAS—hematologic cancer	3.46e-06	6.1e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	3.46e-06	6.09e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.46e-06	6.09e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	3.46e-06	6.09e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.45e-06	6.07e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—FGF2—hematologic cancer	3.43e-06	6.04e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	3.42e-06	6.03e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CDKN1B—hematologic cancer	3.41e-06	6e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CREB1—hematologic cancer	3.4e-06	5.99e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	3.38e-06	5.95e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.37e-06	5.93e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	3.37e-06	5.93e-05	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—AKT1—hematologic cancer	3.37e-06	5.93e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TP53—hematologic cancer	3.37e-06	5.93e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—BRAF—hematologic cancer	3.36e-06	5.92e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.36e-06	5.92e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.36e-06	5.92e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CREB1—hematologic cancer	3.35e-06	5.9e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CASP3—hematologic cancer	3.34e-06	5.88e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL2—hematologic cancer	3.33e-06	5.87e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCL2—hematologic cancer	3.33e-06	5.86e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6R—hematologic cancer	3.32e-06	5.85e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL6—hematologic cancer	3.32e-06	5.84e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CREBBP—hematologic cancer	3.32e-06	5.84e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—BRAF—hematologic cancer	3.31e-06	5.82e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JAK2—hematologic cancer	3.29e-06	5.79e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCL2—hematologic cancer	3.28e-06	5.77e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6R—hematologic cancer	3.27e-06	5.75e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	3.26e-06	5.74e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCND1—hematologic cancer	3.25e-06	5.72e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—JUN—hematologic cancer	3.24e-06	5.71e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.23e-06	5.68e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	3.22e-06	5.67e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—HRAS—hematologic cancer	3.22e-06	5.67e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MDM2—hematologic cancer	3.21e-06	5.65e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.17e-06	5.58e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	3.16e-06	5.57e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	3.14e-06	5.54e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CDKN1A—hematologic cancer	3.14e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.14e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PTEN—hematologic cancer	3.14e-06	5.52e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MTOR—hematologic cancer	3.12e-06	5.5e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	3.12e-06	5.5e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.11e-06	5.48e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	3.11e-06	5.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.1e-06	5.45e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	3.09e-06	5.45e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—KRAS—hematologic cancer	3.08e-06	5.42e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MAPK8—hematologic cancer	3.07e-06	5.4e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.06e-06	5.39e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—AKT1—hematologic cancer	3.06e-06	5.39e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	3.03e-06	5.33e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CG—hematologic cancer	3.02e-06	5.32e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—FGF2—hematologic cancer	3.01e-06	5.3e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3e-06	5.28e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EP300—hematologic cancer	2.99e-06	5.27e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTEN—hematologic cancer	2.99e-06	5.27e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	2.98e-06	5.25e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.97e-06	5.23e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	2.97e-06	5.23e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—FGF2—hematologic cancer	2.96e-06	5.22e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.93e-06	5.16e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	2.93e-06	5.16e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	2.92e-06	5.14e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SRC—hematologic cancer	2.91e-06	5.12e-05	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	2.9e-06	5.1e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JAK2—hematologic cancer	2.88e-06	5.08e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CASP3—hematologic cancer	2.87e-06	5.05e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL2—hematologic cancer	2.87e-06	5.05e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.87e-06	5.05e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CD44—hematologic cancer	2.87e-06	5.05e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—EP300—hematologic cancer	2.85e-06	5.02e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL6—hematologic cancer	2.85e-06	5.02e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.85e-06	5.01e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.85e-06	5.01e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.84e-06	5.01e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—AKT1—hematologic cancer	2.84e-06	5.01e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JAK2—hematologic cancer	2.84e-06	5e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—VEGFA—hematologic cancer	2.83e-06	4.99e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	2.83e-06	4.98e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MDM2—hematologic cancer	2.82e-06	4.96e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—STAT3—hematologic cancer	2.8e-06	4.94e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CREBBP—hematologic cancer	2.8e-06	4.93e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NRAS—hematologic cancer	2.8e-06	4.93e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCND1—hematologic cancer	2.79e-06	4.92e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JUN—hematologic cancer	2.79e-06	4.91e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	2.78e-06	4.9e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MDM2—hematologic cancer	2.77e-06	4.88e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MTOR—hematologic cancer	2.74e-06	4.82e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	2.74e-06	4.82e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.71e-06	4.78e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.71e-06	4.78e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	2.7e-06	4.76e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	2.7e-06	4.75e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MTOR—hematologic cancer	2.7e-06	4.75e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	2.7e-06	4.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.69e-06	4.74e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MAPK3—hematologic cancer	2.68e-06	4.72e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CD—hematologic cancer	2.66e-06	4.68e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	2.64e-06	4.65e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	2.63e-06	4.63e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	2.62e-06	4.61e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MYC—hematologic cancer	2.61e-06	4.59e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TGFB1—hematologic cancer	2.6e-06	4.58e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	2.57e-06	4.53e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EP300—hematologic cancer	2.57e-06	4.53e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.57e-06	4.53e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.54e-06	4.48e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	2.53e-06	4.46e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.52e-06	4.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL2—hematologic cancer	2.52e-06	4.43e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.52e-06	4.43e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.51e-06	4.43e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3R1—hematologic cancer	2.51e-06	4.42e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL6—hematologic cancer	2.5e-06	4.41e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	2.5e-06	4.41e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.5e-06	4.4e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.49e-06	4.39e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.48e-06	4.37e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.48e-06	4.36e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.46e-06	4.34e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.45e-06	4.32e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JUN—hematologic cancer	2.45e-06	4.31e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.44e-06	4.29e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.41e-06	4.25e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.41e-06	4.25e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.41e-06	4.24e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—KRAS—hematologic cancer	2.41e-06	4.24e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.41e-06	4.24e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.39e-06	4.21e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.38e-06	4.2e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.37e-06	4.18e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.37e-06	4.17e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ALB—hematologic cancer	2.35e-06	4.14e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.33e-06	4.11e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.33e-06	4.1e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.32e-06	4.08e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CB—hematologic cancer	2.32e-06	4.08e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.31e-06	4.07e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.31e-06	4.07e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.3e-06	4.06e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.28e-06	4.01e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.27e-06	4e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.26e-06	3.98e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EP300—hematologic cancer	2.26e-06	3.98e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.25e-06	3.96e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.24e-06	3.95e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.24e-06	3.94e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.22e-06	3.91e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.22e-06	3.9e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.21e-06	3.9e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.2e-06	3.87e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.2e-06	3.87e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SRC—hematologic cancer	2.2e-06	3.87e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.19e-06	3.86e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ALB—hematologic cancer	2.16e-06	3.81e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.16e-06	3.8e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TP53—hematologic cancer	2.14e-06	3.77e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.14e-06	3.77e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.12e-06	3.73e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.11e-06	3.72e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.11e-06	3.72e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	2.11e-06	3.71e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.1e-06	3.71e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.08e-06	3.67e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.08e-06	3.66e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.08e-06	3.66e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.07e-06	3.65e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.07e-06	3.65e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	2.05e-06	3.6e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.02e-06	3.56e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTEN—hematologic cancer	2e-06	3.52e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.99e-06	3.51e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.97e-06	3.46e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.96e-06	3.46e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.96e-06	3.45e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL6—hematologic cancer	1.96e-06	3.45e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.94e-06	3.42e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.94e-06	3.41e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.93e-06	3.4e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.91e-06	3.37e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—EP300—hematologic cancer	1.91e-06	3.36e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.9e-06	3.35e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.86e-06	3.27e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.84e-06	3.24e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ALB—hematologic cancer	1.83e-06	3.23e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.82e-06	3.2e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	1.81e-06	3.18e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.8e-06	3.16e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.79e-06	3.15e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.76e-06	3.1e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.75e-06	3.09e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—AKT1—hematologic cancer	1.72e-06	3.03e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—EP300—hematologic cancer	1.71e-06	3.02e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.68e-06	2.97e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.67e-06	2.94e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.65e-06	2.91e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.64e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.63e-06	2.87e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.62e-06	2.85e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.62e-06	2.85e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.59e-06	2.8e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—EP300—hematologic cancer	1.58e-06	2.77e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.55e-06	2.74e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.52e-06	2.68e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.51e-06	2.66e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.48e-06	2.6e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.46e-06	2.56e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.43e-06	2.52e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALB—hematologic cancer	1.42e-06	2.49e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CA—hematologic cancer	1.41e-06	2.49e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.4e-06	2.46e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.36e-06	2.4e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.35e-06	2.38e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.34e-06	2.36e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—EP300—hematologic cancer	1.33e-06	2.35e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.27e-06	2.23e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.25e-06	2.2e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.17e-06	2.05e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AKT1—hematologic cancer	1.15e-06	2.03e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.08e-06	1.9e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.03e-06	1.82e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—EP300—hematologic cancer	1.03e-06	1.81e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.87e-07	1.74e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AKT1—hematologic cancer	9.52e-07	1.68e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AKT1—hematologic cancer	8.06e-07	1.42e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.62e-07	1.34e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AKT1—hematologic cancer	6.22e-07	1.1e-05	CbGpPWpGaD
